1. USA Today. A new stent for angioplasty: use of drug-coated device is ballooning. March 4,2004:Life section.
2. Morice M-C, Serruys PW, Sousa JE, et al., for the RAVEL Study Group. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346:1773–1778.
3. Kimmel SE, Berlin JA, Strom BL, Laskey WK. Development and validation of simplified predictive index for major complications in contemporary percutaneous transluminal coronary angioplasty practice. The Registry Committee of the Society for Cardiac Angiography and Interventions. J Am Coll Cardiol. 1995;26:931–938.
4. Hong MK, Popma JJ, Bairn DS, et al. Frequency and predictors of major in-hospital ischemic complications after planned and unplanned new-device angioplasty from the New Approaches to Coronary Intervention (NACI) registry. Am J Cardiol. 1997;80:40K–49K.
5. De Servi S, Repetto S, Bossi I, et al. Predictors of major in-hospital ischemic complications and length of hospital stay after coronary stenting. G Ital Cardiol. 1998;28:1345–1353.